NetworkNewsBreaks

WednesdayApr 12, 2017 12:26 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on April 12, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: AKDS 15.45% – News: Signs beta site agreement with Yuma Way for Arktic™ Smart Building solution MSDI 8.04% – News: Enters distribution agreement with Ingram Entertainment KSHB 5.38% – News: Posts Q2 2017 results RNVA 5.30% – News: Posts FY 2016 results NURO 5.26% – News: Reporting Q1 2017 results, hosting conference call April 20 PTLF 5.02% – News: Releases overview of holistic pet health practices JNP 4.94% – News: Publishes open letter urging…

Continue Reading

WednesdayApr 12, 2017 12:23 pm

NetworkNewsBreaks – SeeThruEquity Updates Coverage on Medical Transcription Billing, Corp. (NASDAQ: MTBC)

SeeThruEquity recently issued an update on Medical Transcription Billing (NASDAQ: MTBC). The news follows the company’s report of financial results for the quarter and year ended December 31, 2016. MTBC reported full year revenues in 2016 of $24.5 million, a 6% increase over $23.1 million in 2015. The company also reported 65% year-over-year growth in the fourth quarter of 2016 with revenues of $8.8 million. The analyst noted this in the report and attributes the growth primarily to the company’s recent acquisition of MediGain LLC and its subsidiary, Millennium Practice Management, LLC. According to company management, the acquisition of MediGain…

Continue Reading

WednesdayApr 12, 2017 12:06 pm

NetworkNewsBreaks – Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) Schedules End of Phase 2 FDA Meeting, Initiates Phase 3 Development

Ritter Pharmaceuticals (NASDAQ: RTTR) shares are up 15% after the company said that the U.S. Food and Drug Administration (FDA) has agreed to an end of phase 2 meeting. The meeting is expected to take place in the third quarter of 2017 to discuss the results of Ritter’s recently completed phase 2b/3 trial, which demonstrated numerous positive topline results. A full analysis of the data is currently underway. The company also plans to discuss phase 3 plans in preparation of a New Drug Application (NDA) submission of RP-G28 for the treatment of lactose intolerance. "Based on the topline results of…

Continue Reading

WednesdayApr 12, 2017 10:39 am

NetworkNewsBreaks – Grey Cloak Tech, Inc. (GRCK) Completes Acquisition of ShareRails

Grey Cloak Tech, Inc. (OTC: GRCK) this morning announced the completion of its acquisition of ShareRails, a provider of online-to-offline (O2O) e-commerce services that is currently valued at more than $6.4 million by Excel Management Systems. “This is a great opportunity for Grey Cloak Tech,” Fred Covely, CEO of Grey Cloak Tech, stated in the news release. “Our entire management team spent a week in Hong Kong last month with the ShareRails development team. We met with the platform's existing clients, as well as developed new relationships, and recognize that the online-to-offline business opportunities are substantial in the southeast region…

Continue Reading

TuesdayApr 11, 2017 1:17 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on April 11, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: WINT 18.95% – News: Reports completion of final interim safety review of AEROSURF® by Data Safety Monitoring Board RMGN 18.06% – News: Secures contract for second major supply chain customer roll-out in 2017 DTRM 12.05% – News: Determine cloud platform selected by Orion Corporation SNYR 11.11% – News: Launches The Synergy Effect AMMA 10.69% – News: Two alumni win at UFC 210 WTER 7.90% – News: Appoints new members to advisory board ARQL 5.45%…

Continue Reading

TuesdayApr 11, 2017 1:16 pm

NetworkNewsBreaks – Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) Meets Phase 1 Portion of Intratumoral IMO-2125 Combination Trial, Begins Enrolling Phase 2 Trial

Idera Pharmaceuticals (NASDAQ: IDRA) this morning announced the successful completion of the phase 1 portion of the ongoing phase 1/2 clinical trial of intratumoral IMO-2125 for the treatment of anti-PD-1 refractory metastatic melanoma. Enrollment has commenced for the phase 2 portion of the trial, and Idera expects to have overall response rate (ORR) data available in the first quarter of 2018. “There is a very clear unmet medical need for those patients for whom current checkpoint inhibitor therapies are not providing adequate solutions. We are incredibly focused on advancing this program as rapidly as possible for these patients, and we…

Continue Reading

TuesdayApr 11, 2017 11:47 am

NetworkNewsBreaks – Tonix Pharmaceuticals (NASDAQ: TNXP) Shares Rally on Results from U.S. FDA Meeting on TNX-102 SL for PTSD

Shares of Tonix Pharmaceuticals (NASDAQ: TNXP) are up 12% this morning on news that the company has received official minutes from its Initial Cross-Disciplinary Breakthrough Meeting held with the U.S. Food and Drug Administration (FDA) on March 9, 2017.  After being awarded Breakthrough Therapy designation in December 2016, Tonix was invited to meet with the FDA to evaluate the feasibility of accelerating the development and registration of TNX-102 SL for the treatment of posttraumatic stress disorder (PTSD). “The FDA’s standard of evidence for drug approval typically requires two positive Phase 3 trials; however, following our Initial Cross-Disciplinary Breakthrough Meeting in…

Continue Reading

TuesdayApr 11, 2017 10:05 am

NetworkNewsBreaks – Bollente Companies’ (BOLC) trutankless® Line Selected for Multiple Projects by Leading Senior Living Management Company

Bollente Companies, Inc. (OTCQB: BOLC) this morning announced that its innovative trutankless® line of smart water heaters has been selected for both a retrofit project and new construction of townhomes at Friendship Village, a retirement community located in Tempe, Arizona. The property is owned by Life Care Services Corporation, a leading senior living management and development company. “With its small footprint, energy savings and inherent longevity, trutankless is an ideal solution for the senior living industry which is expected to continue to outpace the overall economy,” Michael Stebbins of Bollente Companies stated in this morning’s news release. “Besides all the…

Continue Reading

TuesdayApr 11, 2017 9:40 am

NetworkNewsBreaks – CytoDyn Inc. (CYDY) Adds Dr. Scott A. Kelly to Board of Directors

Biotechnology company CytoDyn Inc. (OTCQB: CYDY) this morning announced the addition of Scott A. Kelly, M.D., FAAPMR, to its board of directors, effective April 10, 2017. With this appointment, the company’s board of directors now includes eight members. “Scott is passionate about target-specific treatments and personalized medicine that improve the lives of patients,” Denis R. Burger, Ph.D., vice chairman and chief science officer of CytoDyn, stated in the news release. “He has been a supporter and significant investor in CytoDyn, and we look forward to his contributions to our Company as a member of our Board.” Kelly brings considerable industry…

Continue Reading

MondayApr 10, 2017 12:55 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on April 10, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: WSTL 9.61% – News: Presentation by CEO, CFO available online AKER 4.62% – News: Begins marketing Heparin PF4 Rapid Test in Puerto Rico ASPU 4.59% – News: Closes $7.5M common stock private placement PME 4.49% – News: Purchases five internationally licensed vessels ORIG 4.37% – News: Receives Nasdaq compliance notice PRQR 3.09% – News: Holding annual general meeting of shareholders on May 10 SHIP 2.86% – News: Adjusts pro-forma capitalization for certain material agreements…

Continue Reading